BioCentury | Mar 4, 2013
Financial News

TearScience completes venture financing

TearScience Inc. , Morrisville, N.C. Business: Ophthalmic, Diagnostic Date completed: 2/26/13 Type: Venture financing Raised: Not disclosed Investor: Healthcare Royalty Partners Note: The company raised an undisclosed amount in a tranched offering for up to $70...
BioCentury | Mar 12, 2012
Clinical News

LipiFlow Thermal Pulsation System ophthalmic data

...in 139 patients with MGD and dry eye symptoms showed that a single treatment with TearScience's...
...were reported. Data were published in Cornea. FDA approved LipiFlow to treat MGD last year. TearScience Inc....
BioCentury | Aug 22, 2011
Company News

TearScience management update

TearScience Inc. , Morrisville, N.C. Business: Ophthalmic, Diagnostic Hired: Diethart Reichardt as SVP of Europe, Middle East and Africa, formerly director of global business development at Sauflon Pharmaceuticals Ltd. WIR Staff...
BioCentury | Jul 18, 2011
Clinical News

LipiFlow Thermal Pulsation System regulatory update

...FDA approved TearScience's LipiFlow Thermal Pulsation System to treat meibomian gland dysfunction (MGD). The device was...
...are of a new type and would not be cleared in a 510(k) premarket notification. TearScience...
...to the blocked meibomian glands to allow the body to resume natural production of lipids. TearScience Inc....
BioCentury | Jun 20, 2011
Company News

TearScience sales and marketing update

...to the blocked meibomian glands to allow the body to resume natural production of lipids. TearScience Inc....
BioCentury | May 10, 2010
Financial News

TearScience completes venture financing

TearScience Inc. , Morrisville, N.C. Business: Ophthalmic, Diagnostic Date completed: 5/5/10 Type: Venture financing Raised: $44.5 million Investors: Essex Woodlands Health Ventures; Investor Growth Capital; General Catalyst Partners; De Novo Ventures; Spray Venture Partners; Quaker BioVentures...
BioCentury | May 6, 2010
Financial News

TearScience raises $44.5 million

...also new investors, joined existing investors De Novo Ventures; Spray Venture Partners; and Quaker BioVentures. TearScience...
Items per page:
1 - 7 of 7
BioCentury | Mar 4, 2013
Financial News

TearScience completes venture financing

TearScience Inc. , Morrisville, N.C. Business: Ophthalmic, Diagnostic Date completed: 2/26/13 Type: Venture financing Raised: Not disclosed Investor: Healthcare Royalty Partners Note: The company raised an undisclosed amount in a tranched offering for up to $70...
BioCentury | Mar 12, 2012
Clinical News

LipiFlow Thermal Pulsation System ophthalmic data

...in 139 patients with MGD and dry eye symptoms showed that a single treatment with TearScience's...
...were reported. Data were published in Cornea. FDA approved LipiFlow to treat MGD last year. TearScience Inc....
BioCentury | Aug 22, 2011
Company News

TearScience management update

TearScience Inc. , Morrisville, N.C. Business: Ophthalmic, Diagnostic Hired: Diethart Reichardt as SVP of Europe, Middle East and Africa, formerly director of global business development at Sauflon Pharmaceuticals Ltd. WIR Staff...
BioCentury | Jul 18, 2011
Clinical News

LipiFlow Thermal Pulsation System regulatory update

...FDA approved TearScience's LipiFlow Thermal Pulsation System to treat meibomian gland dysfunction (MGD). The device was...
...are of a new type and would not be cleared in a 510(k) premarket notification. TearScience...
...to the blocked meibomian glands to allow the body to resume natural production of lipids. TearScience Inc....
BioCentury | Jun 20, 2011
Company News

TearScience sales and marketing update

...to the blocked meibomian glands to allow the body to resume natural production of lipids. TearScience Inc....
BioCentury | May 10, 2010
Financial News

TearScience completes venture financing

TearScience Inc. , Morrisville, N.C. Business: Ophthalmic, Diagnostic Date completed: 5/5/10 Type: Venture financing Raised: $44.5 million Investors: Essex Woodlands Health Ventures; Investor Growth Capital; General Catalyst Partners; De Novo Ventures; Spray Venture Partners; Quaker BioVentures...
BioCentury | May 6, 2010
Financial News

TearScience raises $44.5 million

...also new investors, joined existing investors De Novo Ventures; Spray Venture Partners; and Quaker BioVentures. TearScience...
Items per page:
1 - 7 of 7